Open access
152
Views
4
CrossRef citations to date
0
Altmetric
Review
Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor
Nisha S Joseph1 Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
, Yu-Tzu Tai2 Dana-Farber Cancer Institute, Harvard University, Boston, MA, USA
https://orcid.org/0000-0001-6199-3569
Kenneth C Anderson2 Dana-Farber Cancer Institute, Harvard University, Boston, MA, USACorrespondence[email protected]
& Sagar Lonial1 Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Pages 169-180
|
Published online: 18 Aug 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.